Crestwood Advisors Group LLC Blueprint Medicines Corp Transaction History
Crestwood Advisors Group LLC
- $5.73 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
39Shares Held
8.54MCall Options Held
0Put Options Held
14.8K-
Black Rock Inc. New York, NY6.65MShares$861 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8724KShares$93.7 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL419KShares$54.3 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL155KShares$20 Million0.09% of portfolio
-
Ghost Tree Capital, LLC New York, NY140KShares$18.1 Million4.85% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...